We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Serious or Not, Notify FDA of All Trial Safety Events, Guidance States
Serious or Not, Notify FDA of All Trial Safety Events, Guidance States
April 25, 2012
Trial sponsors should notify the FDA about all adverse events brought to their attention by data monitoring committees (DMC), regardless of whether the safety issue is “serious” or not, according to new guidance.